alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › amyloid-imaging

amyloid-imaging

6 studies tagged amyloid-imaging, dated 2006-08-14 to 2015-05-12. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants 2015-05-12
  2. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques 2012-08-05
  3. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy 2012-07-11

Studies

6 studies carry this tag.

Date range

2006 to 2015

Top journals

  • Acta neuropathologica 1
  • Alzheimer's research & therapy 1
  • Journal of neurochemistry 1
  • NeuroImage 1
  • Neurology 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Alzheimer's research & therapy 2015-05-12 Brain scans and imaging

    We developed a document for use with potential study participants to describe the process of amyloid imaging and the implications of amyloid imaging results; and a disclosure process with attention to ongoing monitoring of both mood and safety to receive this information.

  2. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Acta neuropathologica 2012-08-05 Brain scans and imaging

    The definitive Alzheimer's disease (AD) diagnosis requires postmortem confirmation of neuropathological hallmarks-amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs).

  3. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Neurology 2012-07-11 Brain scans and imaging

    Our results provide direct evidence that new CAA-related hemorrhages occur preferentially at sites of increased amyloid deposition and suggest that PiB-PET imaging may be a useful tool in prediction of incident hemorrhages in patients with CAA.

  4. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurochemistry 2009-02-13 Brain scans and imaging

    The distinctive cortical uptake of the tracer (18)F-FDDNP (2-(1-{6-[(2-fluoroethyl(methyl)amino]-2-naphthyl}ethylidene)malononitrile) in Alzheimer's disease (AD) is believed to be because of its binding to both neurofibrillary tangles (NFTs) and highly fibrillar senile plaques.

  5. Impact of amyloid imaging on drug development in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Nuclear medicine and biology 2007-09-04 Treatments

    Imaging agents capable of assessing amyloid-beta (Abeta) content in vivo in the brains of Alzheimer's disease (AD) subjects likely will be important as diagnostic agents to detect Abeta plaques in the brain as well as to help test the amyloid cascade hypothesis of AD and as an aid to assess the efficacy of anti-amyloid therapeutics currently under development and in clinical trials.

  6. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. NeuroImage 2006-08-14 Treatments

    Deposition of amyloid plaques is believed to be a central event in the development of Alzheimer's disease (AD).

All topic tags with their study counts